After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Intellia Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Intellia Therapeutics Inc is $1.17B. A total of 3.25 million shares were traded on the day, compared to an average of 2.86M shares.
In the most recent transaction, Bhanji Muna sold 265 shares of NTLA for 9.97 per share on Jan 29 ’25. After the transaction, the Director now owns 19,468 company shares. In a previous transaction on Jan 03 ’25, Dube Michael P sold 1,372 shares at 12.18 per share. NTLA shares that VP, Chief Accounting Officer owns now total 45,640.
Among the insiders who sold shares, BASTA JAMES disposed of 7,074 shares on Jan 03 ’25 at a per-share price of $12.18. This resulted in the EVP, General Counsel holding 74,497 shares of NTLA after the transaction. In another insider transaction, Lebwohl David sold 9,557 shares at $12.18 per share on Jan 03 ’25. Company shares held by the EVP, Chief Medical Officer now total 87,666.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NTLA has a high of $34.87 and a low of $8.96.
As of this writing, NTLA has an earnings estimate of -$1.32 per share for the current quarter. EPS was calculated based on a consensus of 23.0 estimates, with a high estimate of -$0.86 per share and a lower estimate of -$1.61.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NTLA’s latest balance sheet shows that the firm has $748.69M in Cash & Short Term Investments as of fiscal 2021. There were $74.02M in debt and $125.83M in liabilities at the time. Its Book Value Per Share was $9.46, while its Total Shareholder’s Equity was $1.04B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NTLA is Buy with a score of 4.40.
